Healthcare - Biotechnology - NASDAQ - US
$ 16.77
-1.47 %
$ 2.79 B
Market Cap
22.07
P/E
Price Target
Average
72.43%
Revenue Forecast
Estimate
18.39%
EBIT
Estimate
--72.34%
Net Income
Estimate
66.64%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ACADIA Pharmaceuticals Inc.
Wall Street analysts predict an average 1-year price target for ACAD of $28.9 , with forecasts ranging from a low of $19 to a high of $39 .
ACAD Lowest Price Target
Wall Street Target
19 USD
13.30%
ACAD Average Price Target
Wall Street Target
28.9 USD
72.43%
ACAD Highest Price Target
Wall Street Target
39 USD
132.56%
REVENUE FORECAST
Revenue Forecast Chart ACAD
EBIT FORECAST
EBIT Forecast Chart ACAD
NET INCOME FORECAST
Net Income Chart ACAD